4.06
price up icon2.27%   0.09
after-market アフターアワーズ: 4.24 0.18 +4.43%
loading

Inovio Pharmaceuticals Inc (INO) 最新ニュース

pulisher
Nov 20, 2024

Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Nov 20, 2024
pulisher
Nov 20, 2024

INOVIO Set to Unveil Q3 2024 Financial Results and Business Insights on November 14! - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

July 25, 2024 - Site Selection Magazine

Nov 20, 2024
pulisher
Nov 20, 2024

What is HC Wainwright's Estimate for INO FY2024 Earnings? - MarketBeat

Nov 20, 2024
pulisher
Nov 19, 2024

Inovio Pharmaceuticals (LTS:0A43) Debt-to-Equity : 0.13 (As of Jun. 2024) - GuruFocus.com

Nov 19, 2024
pulisher
Nov 19, 2024

Inovio Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Nov 19, 2024
pulisher
Nov 19, 2024

INOVIO Reports Third-Quarter Financial Results and Updates on INO-3107 Progress - MyChesCo

Nov 19, 2024
pulisher
Nov 18, 2024

The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals - Benzinga

Nov 18, 2024
pulisher
Nov 18, 2024

Inovio Pharmaceuticals (NASDAQ:INO) Price Target Cut to $5.00 by Analysts at HC Wainwright - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

INOVIO Announces Promising Immunology Data for INO-3107 in RRP Treatment - MyChesCo

Nov 18, 2024
pulisher
Nov 18, 2024

Inovio stock hits 52-week low at $4.15 amid market challenges - Investing.com Nigeria

Nov 18, 2024
pulisher
Nov 18, 2024

Inovio Pharmaceuticals (NASDAQ:INO) Given New $15.00 Price Target at Oppenheimer - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Inovio shares target cut by Oppenheimer, retains outperform on Q3 results - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Inovio Pharma Stock Slips Ahead of Q3 Earnings: Retail’s Bullish - MSN

Nov 17, 2024
pulisher
Nov 17, 2024

Inovio focused on launching global COVID-19 vaccine trial next month - The Jerusalem Post

Nov 17, 2024
pulisher
Nov 17, 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Inovio Pharmaceuticals Third Quarter 2024 Earnings: US$0.89 loss per share (vs US$1.52 loss in 3Q 2023) - Yahoo Finance

Nov 16, 2024
pulisher
Nov 16, 2024

Inovio to begin mid-stage study of COVID-19 vaccine candidate - Reuters.com

Nov 16, 2024
pulisher
Nov 15, 2024

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

Nov 15, 2024
pulisher
Nov 15, 2024

Royal Bank of Canada Cuts Inovio Pharmaceuticals (NASDAQ:INO) Price Target to $6.00 - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024
pulisher
Nov 15, 2024

Inovio: Q3 Earnings Snapshot - mySA

Nov 15, 2024
pulisher
Nov 15, 2024

Q3 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... - Yahoo Finance

Nov 15, 2024
pulisher
Nov 14, 2024

Inovio Pharmaceuticals (INO) Q3 2024 Earnings Call Transcript - Barchart

Nov 14, 2024
pulisher
Nov 14, 2024

Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Nov 14, 2024
pulisher
Nov 14, 2024

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

INOVIO Reports Third Quarter 2024 Financial Results and Recent B - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Inovio Pharmaceuticals Inc (INO) Q3 2024 Earnings Call Highlights: Progress in INO-3107 ... By GuruFocus - Investing.com Canada

Nov 14, 2024
pulisher
Nov 14, 2024

INO-3107 shows promise in reducing surgeries for RRP patients By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 13, 2024

Anal Cancer Market Revenue to Expand Significantly by 2034, States DelveInsight Report | Incyte Corp, BioMimetix, Inovio Pharma, Merck Sharp & Dohme, Dustin Deming, Advaxis - The Globe and Mail

Nov 13, 2024
pulisher
Nov 13, 2024

A Preview Of Inovio Pharmaceuticals's Earnings - Benzinga

Nov 13, 2024
pulisher
Nov 13, 2024

Anal Cancer Market Revenue to Expand Significantly by 2034, - openPR

Nov 13, 2024
pulisher
Nov 13, 2024

INO-3107 shows promise in reducing surgeries for RRP patients - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Nov 12, 2024
pulisher
Nov 11, 2024

Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch

Nov 11, 2024
pulisher
Nov 08, 2024

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Nov 08, 2024
pulisher
Nov 07, 2024

Inovio Pharmaceuticals (INO) Set to Announce Earnings on Thursday - MarketBeat

Nov 07, 2024
pulisher
Nov 06, 2024

Inovio Pharmaceuticals Inc. stock rises Wednesday, still underperforms market - MarketWatch

Nov 06, 2024
pulisher
Nov 06, 2024

INOVIO to Present at Upcoming Scientific Conferences - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

INOVIO to Present Breakthrough DNA Vaccine Research at Two Major Scientific Conferences | INO Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 06, 2024

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 - Marketscreener.com

Nov 06, 2024
pulisher
Nov 06, 2024

INOVIO to Report Q3 2024 Financial Results on Nov 14 - Chicago Star Media

Nov 06, 2024
pulisher
Nov 06, 2024

INOVIO (INO) Sets Q3 2024 Earnings Call: DNA Medicine Updates Expected | INO Stock News - StockTitan

Nov 06, 2024
pulisher
Nov 04, 2024

Algoma Central (ALC-T) QuotePress Release - The Globe and Mail

Nov 04, 2024
pulisher
Nov 02, 2024

INO (Inovio Pharmaceuticals) Ending Cash Position : $34.39 Mil (As of Jun. 2024) - GuruFocus.com

Nov 02, 2024
pulisher
Oct 30, 2024

Inovio Pharmaceuticals Inc. stock remains steady Wednesday, still outperforms market - MarketWatch

Oct 30, 2024
pulisher
Oct 30, 2024

Inovio Pharmaceuticals (LTS:0A43) Probability of Financial Distress (%) : 0.27% (As of Oct. 30, 2024) - GuruFocus.com

Oct 30, 2024
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
大文字化:     |  ボリューム (24 時間):